Consumer Health Business News: Rebrands for Takeda OTC And Reckitt, DSM Acquires, Enzymatica Raises Funds
A round-up of the latest consumer health industry news: Takeda completes the sale of its Japanese OTC business, which has rebranded as Alinamin; Reckitt drops the "Benckiser" from its name to signal new approach; Enzymatica looks to raise funds as COVID continues to bite; and Royal DSM expands its portfolio through a new deal with Amyris.
You may also be interested in...
Brands under development and recent acquisitions including EcoFabulous, Costa Brazil and Terasana will account for around 20% of overall 2021 revenue in Amyris’ Consumer business, according to the firm, which aspires to be the “L’Oreal of clean beauty.”
DSM says its nutrition segment, which includes human and animal nutrition and personal care, has a “unique business model combining 'global products' and 'local solutions'” and showed 6% organic sales growth for 2020 and 8% for Q4.
Stada to launch innovative common cold spray ViruProtect in four Nordic markets in 2021 after striking a new agreement with Sweden's Enzymatica.